SD BioSensor, Inc
KSC: 137310.KS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Korea Exchange
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- CEO
- Hyo Keun Lee
- Employees
- 576
- Headquarters
- Suwon, South Korea
- IPO year
- 2021
- Market cap
- ₩951B
- Website
- https://www.sdbiosensor.com
Loading 137310…
Loading profile data…Frequently asked questions about 137310
What does SD BioSensor, Inc (137310.KS) do?
SD BioSensor Inc., an in-vitro diagnostic company, provides point-of-care diagnostic solutions in South Korea and internationally. The company's products include STANDARD Q, which provides various rapid test parameters comprising COVID-19 products and other parameters; STANDARD F, a multi-parametric and random accessible FIA system that provides...
Where does 137310.KS trade?
SD BioSensor, Inc (137310.KS) trades on the Korea Exchange.
What sector is 137310.KS in?
SD BioSensor, Inc (137310.KS) operates in the Healthcare sector, specifically in the Medical - Instruments & Supplies industry.
Who is the CEO of SD BioSensor, Inc?
Hyo Keun Lee is the chief executive officer of SD BioSensor, Inc (137310.KS).
Where is SD BioSensor, Inc headquartered?
SD BioSensor, Inc is headquartered in South Korea.
Does 137310.KS pay a dividend?
Yes — SD BioSensor, Inc (137310.KS) paid a trailing twelve-month dividend of KRW 200.00 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 137310.KS go public?
SD BioSensor, Inc (137310.KS) completed its initial public offering in 2021.